0001165527-19-000089 Sample Contracts

AMENDMENT NO. 1 TO VETO CELL PRODUCTION AND CLINICAL TRIAL PROGRAM AGREEMENT

Program Agreement • May 20th, 2019 • Cell Source, Inc. • Pharmaceutical preparations

• Contract Type
  Program Agreement
• Filed
  May 20th, 2019
• Company
  Cell Source, Inc.
• Industry
  Pharmaceutical preparations

This Amendment No. 1 to the Veto Cell Production and Clinical Trial Program Agreement (“Amendment”) is made and entered into as of April 4, 2019 by and between Cell Source Limited (“Cell Source”) and The University of Texas M.D. Anderson Cancer Center (“MD Anderson”), a member institution of The University of Texas System (“System”).